Use RNA-Seq to Sharpen Diagnostic Precision

RNA sequencing (RNA-seq) can be used to measure gene expression patterns and gene fusions, crucial for accurate diagnosis and treatment planning. 

RNA-seq provides a comprehensive view of gene activity, creating a unique tumor fingerprint for classification into subtypes. Advanced algorithms and AI enhance this. Unbiased RNA-seq gives the complete picture, as it also detects all gene fusions. 

For more insights on this topic, watch the interview with Dr. Thoas Fioretos, MD, Professor of Clinical Genetics, Lund University and Qlucore co-founder.   

Regulatory approved solutions are already available on the market today. Qlucore Diagnostics BCP-ALL is CE-marked according to IVDR. It aids in the initial classification and management of pediatric patients with suspected or diagnosed BCP-ALL (up to 7% increased patient coverage compared to current methods). 

This is a first step to a broader use of RNA-seq in the clinical setting. Qlucore customers are also using the Qlucore Insights (research use only) test for lung cancer samples and development is well progressed in the field of bladder cancer and AML.